Research
We study members of the TAM-family of receptor tyrosine kinases (TYRO3, AXL, and MERTK) in cancer and the effects of TAM inhibition asa disease treatment.
Douglas Graham, MD, PhD
Center Director of Aflac Cancer and Blood Disorders Center
Center Director of Aflac Cancer and Blood Disorders Center
We study members of the TAM-family of receptor tyrosine kinases (TYRO3, AXL, and MERTK) in cancer and the effects of TAM inhibition asa disease treatment.